Mosbrooker Eric
Insider CIK 1715283 · HZNP SVP, Orphan Business Unit · RNA Chief Commercial Officer, Director · BOLD SVP, Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 177,188 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 50,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 79,413 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | F Tax w/h | 2025-12-17 | 2025-12-19 | 11,426 | $71.87 | $821.2K | 79,010 | SEC↗ |
| RNA Avidity Biosciences, Inc. | F Tax w/h | 2025-12-17 | 2025-12-19 | 36,564 | $71.87 | $2.63M | 90,436 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-12-17 | 2025-12-19 | 72,000 | — | $0 | 127,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-10-03 | 2025-10-07 | 6,562 | — | $0 | 177,188 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-10-03 | 2025-10-07 | 6,562 | $9.05 | $59.4K | 61,562 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-10-03 | 2025-10-07 | 6,562 | $45.38 | $297.8K | 55,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-09-03 | 2025-09-05 | 6,563 | — | $0 | 183,750 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-09-03 | 2025-09-05 | 6,563 | $47.07 | $308.9K | 55,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-09-03 | 2025-09-05 | 6,563 | $9.05 | $59.4K | 61,563 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-08-06 | 2025-08-08 | 124,687 | — | $0 | 190,313 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 6,120 | $44.06 | $269.6K | 55,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-08-06 | 2025-08-08 | 124,687 | $44.06 | $5.49M | 61,120 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-08-06 | 2025-08-08 | 124,687 | $9.05 | $1.13M | 185,807 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 61,120 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2021-08-25 | 2021-08-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | D To issuer deriv | 2020-01-15 | 2020-01-15 | 87,750 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | U Tender | 2020-01-15 | 2020-01-15 | 26,919 | $60.00 | $1.62M | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | F Tax w/h | 2019-12-12 | 2019-12-16 | 4,881 | $59.37 | $289.8K | 26,919 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award deriv | 2019-01-03 | 2019-01-04 | 87,750 | — | $0 | 87,750 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | A Award | 2018-01-03 | 2019-01-04 | 31,500 | — | $0 | 31,800 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-11-01 | 2017-11-02 | 4,435 | — | $0 | 13,306 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2017-11-01 | 2017-11-02 | 2,315 | $13.83 | $32.0K | 3,585 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2017-11-01 | 2017-11-02 | 4,435 | — | $0 | 5,900 | SEC↗ |